TSE:4488 stock news
This page provides real-time market news, earnings updates, and company announcements related to AI inside, Inc. (TSE:4488).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-19 13:30 JST
Radian Group (NYSE:RDN) Misses Q4 CY2025 Revenue Estimates
Finviz2026-02-18 22:06:39
Brittany Kaiser, CEO of AlphaTON Capital ($ATON), Goes Live on X to Reveal the Strategy Behind Recent AI Infrastructure Play
Finviz2026-02-18 23:24:09
Meta reboots smartwatch plan, aims debut in 2026, the Information reports
101 finance2026-02-18 23:36:13
Massive AI Investments Spark Market Concerns: Amazon’s Stock Off to a Poor Start This Year, But Wall Street Still Sees It as an “Undervalued Winner”
金融界2026-02-19 00:02:39
Nvidia sells all its Arm shares, but Arm's stock price rises slightly against the trend
华尔街见闻2026-02-19 00:34:00
Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating
Finviz2026-02-19 00:42:11
Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds
Finviz2026-02-19 00:45:38
Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?
Finviz2026-02-19 00:45:38
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
Finviz2026-02-19 00:45:39
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
Finviz2026-02-19 00:45:38
Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation
Finviz2026-02-19 00:45:39
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Finviz2026-02-19 00:45:39
TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook
Finviz2026-02-19 00:48:34
Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026
Finviz2026-02-19 02:03:12
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37
RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
Finviz2026-02-19 02:33:44
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
Finviz2026-02-19 02:33:44
Jefferies Assigns 65-75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III
Finviz2026-02-19 02:33:45
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials
Finviz2026-02-19 02:33:45
Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
Finviz2026-02-19 02:36:45
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45
Druckenmiller Makes Major Portfolio Adjustments!
美投investing2026-02-19 03:08:56
Carvana Shares Drop as Rising Expenses Reduce Profits for Used Car Retailer
101 finance2026-02-19 03:15:43
What kind of software will be eliminated by AI?
华尔街见闻2026-02-19 03:35:14
Nvidia sells all its Arm shares, but Arm's stock price rises slightly against the trend
华尔街见闻2026-02-19 00:34:00
Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating
Finviz2026-02-19 00:42:11
Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds
Finviz2026-02-19 00:45:38
Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?
Finviz2026-02-19 00:45:38
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
Finviz2026-02-19 00:45:39
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
Finviz2026-02-19 00:45:38
Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation
Finviz2026-02-19 00:45:39
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Finviz2026-02-19 00:45:39
TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook
Finviz2026-02-19 00:48:34
Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026
Finviz2026-02-19 02:03:12
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37
RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
Finviz2026-02-19 02:33:44
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
Finviz2026-02-19 02:33:44
Jefferies Assigns 65-75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III
Finviz2026-02-19 02:33:45
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials
Finviz2026-02-19 02:33:45
Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
Finviz2026-02-19 02:36:45
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45
Druckenmiller Makes Major Portfolio Adjustments!
美投investing2026-02-19 03:08:56
Carvana Shares Drop as Rising Expenses Reduce Profits for Used Car Retailer
101 finance2026-02-19 03:15:43
What kind of software will be eliminated by AI?
华尔街见闻2026-02-19 03:35:14
TSE:4488 stock price change
On the last trading day, TSE:4488 stock closed at 2390.00 JPY, with a price change of -7.00% for the day.
Trade stock futuresTSE:4488 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more